LPS-induced release of IL-1β, IL-1Ra, IL-6, and TNF-α in whole blood from patients with familial hypercholesterolemia: No effect of cholesterol-lowering treatment

Journal of Interferon and Cytokine Research

Volumn 26, Issue 2, 2006, Pages 101-107

  De Bont, Natasja ^a   Netea, Mihai G ^a   Rovers, Chantal ^a   Smilde, Tineke ^a   Hijmans, Anneke ^a   Demacker, Pierre N M ^a   Van Der Meer, Jos W M ^a   Stalenhoef, Anton F H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; SIMVASTATIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD CULTURE; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOUBLE BLIND PROCEDURE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE EXPRESSION; HETEROZYGOSITY; HUMAN; HYPERLIPOPROTEINEMIA; INFLAMMATION; MALE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; ANTICHOLESTEREMIC AGENTS; FEMALE; HEPTANOIC ACIDS; HETEROZYGOTE DETECTION; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PYRROLES; SIMVASTATIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644839504     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.26.101     Document Type: Article

References (39)

1. Lynn WA, Cohen J. Adjunctive therapy for septic shock: a review of experimental approaches. Clin. Infect. Dis. 1995;20:143-158.
2. Lopes-Virella MF. Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease. Eur. Heart J. 1993;14(Suppl K):118-124.
3. Saikku P, Leinonen M, Mattila K, Nieminen MS, Huttunen JK, Ekman, M.R. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-986.
4. Sinensky M, Logel J. Inhibition of degradation of 3-hydroxy-3- methylglutaryl coenzyme A reductase by mevinolin. J. Biol. Chem. 1983;258:8547-8549.
5. Van-Lenten BJ, Fogelman AM, Haberland ME, Edwards PA. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA 1986;83:2704-2708.
6. Navab M, Hough GP, Van-Lenten BJ, Berliner JA, Fogelman AM. Low-density lipoproteins transfer bacterial lipopolysaccharides across endothelial monolayers in a biologically active form. J. Clin. Invest. 1988;81:601-605.
7. Cathcart MK, McNally AK, Morel DW, Chisolm GM. Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin. J. Immunol. 1989;142:1963-1969.
8. Berliner JA, Haberland ME. The role of oxidized low-density lipoproteins in atherogenesis. Curr. Opin. Lipidol. 1993;4:373-381.
9. Yla-Herttuala S. Macrophages and oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Ann. Med. 1991;23:561-567.
10. Wang X, Feuerstein GZ, Gu JL, Lysko PG, Yue TL. Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells. Atherosclerosis 1995;115:89-98.
11. Takahashi M, Ikeda U, Masuyama J, Kitagawa S, Kasahara T, Saito M, Kano S, Shimada K. Involvement of adhesion molecules in human monocyte adhesion to and transmigration through endothelial cells in vitro. Atherosclerosis 1994;108:73-81.
12. Seitz CS, Kleindienst R, Xu Q, Wick G. Coexpression of heat-shock protein 60 and intercellular-adhesion molecule-1 is related to increased adhesion of monocytes and T cells to aortic endothelium of rats in response to endotoxin. Lab. Invest. 1996;74:241-252.
13. Reidy MA, Bowyer DE. Distortion of endothelial repair. The effect of hypercholesterolaemia on regeneration of aortic endothelium following injury by endotoxin. A scanning electron microscope study. Atherosclerosis 1978;29:459-466.
14. Brito BE, Romano EL, Grunfeld C. Increased lipopolysaccharide-induced tumour necrosis factor levels and death in hypercholesterolaemic rabbits. Clin. Exp. Immunol. 1995;101:357-361.
15. Henninger DD, Gerritsen ME, Granger DN. Low-density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli. Circ. Res. 1997;81:274-281.
16. Netea MG, Demacker PN, Kullberg BJ, Boerman OC, Verschueren I, Stalenhoef AFH, Van der Meer JWM. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J. Clin. Invest. 1996;97:1366-1372.
17. 2-integrins and CD14 by peripheral blood mononuclear cells of patients with homozygous familial hypercholesterolemia. Atherosclerosis 1998;141:99-105.
18. Leirisalo-Repo M, Jaattela M, Gylling H, Miettinen TA, Repo H. Phagocyte function in familial hypercholesterolaemia: peripheral blood monocytes exposed to lipopolysaccharide show increased tumour necrosis factor production. Scand. J. Immunol. 1990;32:679-685.
19. de Bont N, Netea MG, Rovers C, Smilde TJ, Demacker PNM, Van der Meer JWM, Stalenhoef AFH. LPS-induced cytokine production and expression of LPS receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors. Atherosclerosis 1998;139:147-152.
20. Esfahani M, Bigler RD, Alfieri JL, Lund-Katz S, Baum JD, Scerbo L. Cholesterol regulates the cell surface expression of glycophospholipid-anchored CD14 antigen on human monocytes. Biochim. Biophys. Acta 1993;1149:217-223.
21. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
22. Pahan K, Sheikh FG, Namboodiri AM, Singh I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J. Clin. Invest. 1997;100:2671-2679.
23. Terkeltaub R, Solan J, Barry MJ, Santoro D, Bokoch GM. Role of the mevalonate pathway of isoprenoid synthesis in IL-8 generation by activated monocytic cells. J. Leukoc. Biol. 1994;55:749-755.
24. Kim SY, Guijarro C, O'Donnell MP, Kasiske BL, Kim Y, Keane WF. Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin. Kidney Int. 1995;48:363-371.
25. Van-Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc. Natl. Acad. Sci. USA 1992;89:4845-4849.
26. Demacker PN, Hijmans AG, Brenninkmeijer BJ, Jansen AP, van't-Laar A. Five methods for determining low-density lipoprotein cholesterol compared. Clin. Chem. 1984;30:1797-1800.
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972;18:499-502.
28. van Deuren M, van der Ven-Jongekrijg J, Keuter M, Demacker PNM, van der Meer JWM. Cytokine production in whole blood cultures. J. Int. Fed. Clin. Chem. 1993;5:216-221.
29. Netea MG, Drenth JP, De-Bont N, Hijmans A, Keuter M, Dharmana E, Demacker PNM, Van der Meer JWM. A semi-quantitative reverse transcriptase polymerase chain reaction method for measurement of mRNA for TNF-alpha and IL-1 beta in whole blood cultures: its application in typhoid fever and exentric exercise. Cytokine 1996;8:739-744.
30. Drenth JP, Van-Uum SH, van-Deuren M, Pesman GJ, Van-der-Ven-Jongekrijg J, van-der-Meer JW. Endurance run increases circulating IL-6 and IL- 1Ra but downregulates ex vivo TNF-alpha and IL-1 beta production. J. Appl. Physiol. 1995;79:1497-1503.
31. Li H, Freeman MW, Libby P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J. Clin. Invest. 1995;95:122-133.
32. Libby P, Sukhova G, Lee RT, Galis ZS. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J. Cardiovasc. Pharmacol. 1995;25(Suppl 2):S9-12.
33. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
34. Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, Kirsch G, Mentel R, Furll B, Freudenberg M, Schmitz G, Stelter F, Schutt C. Lipopolysaccharide- binding protein is required to combat a murine gram-negative bacterial infection. Nature 1997;389:742-745.
35. Wurfel MM, Monks BG, Ingalls RR, Dedrick RL, Delude R, Zhou D, Lamping N, Schumann RR, Thieringer R, Fenton MJ, Wright SD, Golenbock D. Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J. Exp. Med. 1997;186:2051-2056.
36. Pan HY, DeVault AR, Wang-Iverson D, Ivashkir BN, Swanson N, Sugerman A. Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin. J. Clin. Pharmacol. 1990;30:1128-1135.
37. Koga T, Shimada Y, Kuroda M, Tsujita Y, Hasegawa K, Yamazaki M. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Biochim. Biophys. Acta 1990;1045:115-120.
38. Endo A. Chemistry, biochemistry, and pharmacology of HMG-CoA reductase inhibitors. Klin. Wochenschr. 1988;66:421-427.
39. Porreca E, Di-Febbo C, Barbacane RC, Panara MR, Cuccurullo F, Conti P. Effect of interleukin-1 receptor antagonist on vascular smooth muscle cell proliferation. Atherosclerosis 1993;99:71-78.